Primary Aldosteronism clinical trials

Explore recruiting primary aldosteronism clinical trials.

Recruiting primary aldosteronism studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Primary Aldosteronism trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PENTALON - Pilot study for the evaluation of [68Ga]Ga-PentixaFor PET imaging for the identification of unilateral adrenal secretion of ALdosterON in patients with primary aldosteronism.

France

Phase II and Phase III (Integrated) EU CTIS Study details

Subtyping Primary Aldosteronism with Para-chloro-2-[18F]fluoroethyl-etomidate ([18F]CETO)

Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

CXCR4-directed [68Ga]Ga-PentixaFor PET/CT vs AVS performance in a diagnoStic randomized Trial Ultimately comparing hypertenSion outcome in primary aldosteronism (CASTUS trial)

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Baxdrostat in Adult Participants with Primary Aldosteronism

Germany, Italy, France, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A trial to learn how baxdrostat affects the heartbeat in healthy participants

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Primary Aldosteronism trials by city

Primary Aldosteronism in Toronto Primary Aldosteronism in Vancouver Primary Aldosteronism in Montreal Primary Aldosteronism in Calgary Primary Aldosteronism in Edmonton Primary Aldosteronism in Ottawa Primary Aldosteronism in Winnipeg Primary Aldosteronism in Quebec City Primary Aldosteronism in Hamilton Primary Aldosteronism in Kitchener Primary Aldosteronism in London Primary Aldosteronism in Halifax Primary Aldosteronism in New York Primary Aldosteronism in Los Angeles Primary Aldosteronism in Chicago Primary Aldosteronism in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease